Regulation of calcium-sensitive tyrosine kinase Pyk2 by angiotensin II in endothelial cells - Roles of Yes tyrosine kinase and tyrosine phosphatase SHP-2

被引:69
作者
Tang, H
Zhao, ZZJ
Landon, EJ
Inagami, T
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Div Hematol, Nashville, TN 37232 USA
关键词
D O I
10.1074/jbc.275.12.8389
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Calcium-sensitive tyrosine kinase Pyk2 has been implicated in the regulation of ion channels, cellular adhesion, and mitogenic and hypertrophic reactions. In this study, we have investigated the regulation of Pyk2 by angiotensin II (Ang II) in pulmonary vein endothelial cells. We found that the Ang II-induced tyrosine phosphorylation of Pyk2, which requires the activity of Src family kinase, was specifically regulated by the Src family kinase member, Yes kinase, Moreover, we identified for the first time the constitutive association of Pyk2 with an Src homology 2 (SH2) domain-containing tyrosine phosphatase SHP-2. SHP-2 interacts with Pyk2 through a region other than its SH2 domains. Pyk2 can be dephosphorylated in vitro in SHP-2 immunoprecipitates and in intact cells expressing an NH, terminus-truncated form of SHP-2, which lacks the two SH2 domains but has an enhanced phosphatase activity. Ang II activates the endogenous SHP-2, Finally, the SHP-2-mediated dephosphorylation of Pyk2 correlates with the negative effect of SHP-2 on the Ang II-induced activation of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase. Thus, the balance of Pyk2 tyrosine phosphorylation in response to Ang II is controlled by Yes kinase and by a tyrosine phosphatase SHP-2 in endothelial cells.
引用
收藏
页码:8389 / 8396
页数:8
相关论文
共 61 条
[11]   A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation [J].
Dikic, I ;
Tokiwa, G ;
Lev, S ;
Courtneidge, SA ;
Schlessinger, J .
NATURE, 1996, 383 (6600) :547-550
[12]   Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells [J].
Eguchi, S ;
Iwasaki, H ;
Inagami, T ;
Numaguchi, K ;
Yamakawa, T ;
Motley, ED ;
Owada, KM ;
Marumo, F ;
Hirata, Y .
HYPERTENSION, 1999, 33 (01) :201-206
[13]   SH2-CONTAINING PHOSPHOTYROSINE PHOSPHATASE AS A TARGET OF PROTEIN-TYROSINE KINASES [J].
FENG, GS ;
HUI, CC ;
PAWSON, T .
SCIENCE, 1993, 259 (5101) :1607-1611
[14]   β-chemokine receptor CCR5 signals via the novel tyrosine kinase RAFTK [J].
Ganju, RK ;
Dutt, P ;
Wu, LJ ;
Newman, W ;
Avraham, H ;
Avraham, S ;
Groopman, JE .
BLOOD, 1998, 91 (03) :791-797
[15]   Drug therapy - Angiotensin receptors and their antagonists [J].
Goodfriend, TL ;
Elliott, ME ;
Catt, KJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (25) :1649-1654
[16]   An intracellular calcium signal activates p70 but not p90 ribosomal S6 kinase in liver epithelial cells [J].
Graves, LM ;
He, YQ ;
Lambert, J ;
Hunter, D ;
Li, XN ;
Earp, HS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1920-1928
[17]   Angiotensin II signaling in vascular smooth muscle - New concepts [J].
Griendling, KK ;
UshioFukai, M ;
Lassegue, B ;
Alexander, RW .
HYPERTENSION, 1997, 29 (01) :366-373
[18]  
Guo XYD, 1998, BLOOD, V92, p253A
[19]   Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor - Study of Lck- and FynT-dependent T cell activation [J].
Hanke, JH ;
Gardner, JP ;
Dow, RL ;
Changelian, PS ;
Brissette, WH ;
Weringer, EJ ;
Pollok, K ;
Connelly, PA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :695-701
[20]  
Hildebrand JD, 1996, MOL CELL BIOL, V16, P3169